We have demonstrated that the ALS-associated R473 TBK1 mutation inhibits p62 and RIPK1 phosphorylation, leading to an RIPK1-mediated increase in IL-6 levels without altering the autophagic flux. Here, TBK1 is linked to amyotrophic lateral sclerosis.